首页> 美国卫生研究院文献>Mediators of Inflammation >Anti-HMGB1 Monoclonal Antibody Ameliorates Immunosuppression after Peripheral Tissue Trauma: Attenuated T-Lymphocyte Response and Increased Splenic CD11b+Gr-1+ Myeloid-Derived Suppressor Cells Require HMGB1
【2h】

Anti-HMGB1 Monoclonal Antibody Ameliorates Immunosuppression after Peripheral Tissue Trauma: Attenuated T-Lymphocyte Response and Increased Splenic CD11b+Gr-1+ Myeloid-Derived Suppressor Cells Require HMGB1

机译:抗HMGB1单克隆抗体可改善周围组织创伤后的免疫抑制:减弱的T淋巴细胞反应和增加的脾CD11b + Gr-1 +髓样来源的抑制细胞需要HMGB1

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Although tissue-derived high mobility group box 1 (HMGB1) is involved in many aspects of inflammation and tissue injury after trauma, its role in trauma-induced immune suppression remains elusive. Using an established mouse model of peripheral tissue trauma, which includes soft tissue and fracture components, we report here that treatment with anti-HMGB1 monoclonal antibody ameliorated the trauma-induced attenuated T-cell responses and accumulation of CD11b+Gr-1+ myeloid-derived suppressor cells in the spleens seen two days after injury. Our data suggest that HMGB1 released after tissue trauma contributes to signaling pathways that lead to attenuation of T-lymphocyte responses and enhancement of myeloid-derived suppressor cell expansion.
机译:尽管组织来源的高迁移率族盒1(HMGB1)涉及创伤后炎症和组织损伤的许多方面,但其在创伤诱导的免疫抑制中的作用仍然难以捉摸。我们使用已建立的包括软组织和骨折成分在内的周围组织创伤的小鼠模型,在这里我们报告说,抗HMGB1单克隆抗体的治疗改善了创伤诱导的减毒T细胞反应和CD11b + Gr-1 + 骨髓来源的抑制细胞。我们的数据表明,组织创伤后释放的HMGB1有助于导致T淋巴细胞反应减弱和髓样抑制细胞扩增增强的信号通路。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号